Short‐term reactogenicity and gender effect of anthrax vaccine: analysis of a 1967–1972 study and review of the 1955–2005 medical literature

@article{McNeil2007ShorttermRA,
  title={Short‐term reactogenicity and gender effect of anthrax vaccine: analysis of a 1967–1972 study and review of the 1955–2005 medical literature},
  author={M. McNeil and I-Shan Chiang and J. Wheeling and Yujia Zhang},
  journal={Pharmacoepidemiology and Drug Safety},
  year={2007},
  volume={16}
}
In the 1960s, the Centers for Disease Control and Prevention (CDC) held the investigational new drug (IND) application for the anthrax vaccine and collected short‐term safety data from approximately 16 000 doses administered to almost 7000 individuals. While some recent anthrax vaccine safety studies have suggested that women experience more injection site reactions (ISRs), to our knowledge the IND safety data were not previously examined for a gender‐specific difference. 
Countering Anthrax : Vaccines and Immunoglobulins
Vaccines: countering anthrax: vaccines and immunoglobulins.
  • J. Grabenstein
  • Medicine
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2008
Anthrax vaccination strategies.
Risk Factors associated with Lack of Seroprotection against Type 3 Poliovirus.
...
1
2
3
...

References

SHOWING 1-10 OF 35 REFERENCES
Analysis of Adverse Events after Anthrax Immunization in US Army Medical Personnel
ADVERSE REACTIONS AFTER SMALLPOX VACCINATION
  • B. Feery
  • Medicine
  • The Medical journal of Australia
  • 1977
...
1
2
3
4
...